Vaccine News and Research

Latest Vaccine News and Research

Interim analysis of phase 3 study shows excellent efficacy of SARS-CoV-2 vaccine

South African study data were used to evaluate the safety of the vaccine in the results just published, but not its efficacy [which refers to the percentage reduction of disease].

9 Dec 2020

Virginia Tech researchers awarded NIH grant to develop Zika virus vaccine

Flaviviruses -- a group of viruses transmitted by ticks or mosquitoes -- infect an estimated 400 million people annually with diseases like yellow fever, Dengue fever, West Nile virus, and, most recently, Zika virus.

9 Dec 2020

Different SARS-CoV-2 neutralization assays are reliable and concordant for antibody monitoring

A recent study by US researchers, currently available on the medRxiv preprint server, evaluated several cell-based assays that are under validation for determining correlates of protection in individuals with symptomatic coronavirus disease (COVID-19) and vaccine studies – and demonstrated their high concordance with both live and pseudotyped virions.

9 Dec 2020

Obesity increases the risk of severe COVID-19, study finds

Researchers reveal that being overweight and obese are common risk factors for developing severe COVID-19. However, they suggested further assessment of metabolic parameters, including body mass index (BMI), waist-hip ratio, and insulin levels, to estimate the risk.

9 Dec 2020

UofL receives DoD funding to develop a nasal spray for preventing COVID-19

The University of Louisville has received funding from the U.S. Department of Defense (DoD) to develop a nasal spray to prevent serious viral respiratory infections such as COVID-19 using Q-Griffithsin, a drug compound developed and co-owned by UofL.

9 Dec 2020

Considerable COVID-19 vaccination hesitancy in UK may affect herd immunity, study finds

Scientists from the Imperial College London and the Imperial College Healthcare NHS Trust, UK, have conducted a cross-sectional, questionnaire-based survey to evaluate the public’s willingness to receive coronavirus disease 2019 (COVID-19) vaccination and their attitude toward prioritization.

9 Dec 2020

It’s time to scare people about COVID

I still remember exactly where I was sitting decades ago, during the short film shown in class: For a few painful minutes, we watched a woman talking mechanically, raspily through a hole in her throat, pausing occasionally to gasp for air.

9 Dec 2020

Interim results show Oxford COVID-19 vaccine protects against symptomatic disease

First full results from interim analysis confirm that the Oxford COVID-19 vaccine (AZD1222) has an acceptable safety profile and is efficacious against symptomatic COVID-19 disease, with no hospitalizations or severe disease reported in the COVID-19 vaccine group so far.

9 Dec 2020

New report underscores the need to implement home care in all pandemic planning

Tens of thousands of Massachusetts residents depend on home care to support their health as they age or cope with physical challenges. That care often requires close personal contact, increasing the risk of contracting COVID-19 among both home-care clients and the aides who provide their care.

8 Dec 2020

Researchers assess the binding behavior of SARS-CoV-2 virus

The binding of a SARS-CoV-2 virus surface protein spike -- a projection from the spherical virus particle -- to the human cell surface protein ACE2 is the first step to infection that may lead to COVID-19 disease.

8 Dec 2020

UC Davis Health joins with Novavax to test a new experimental coronavirus vaccine

Despite the encouraging news of potentially successful COVID-19 vaccine trials, there is not yet an FDA-approved vaccine available. Research into other effective coronavirus vaccines continues, including at UC Davis Health.

8 Dec 2020

Researchers develop new method to evaluate vaccine safety

A research group at the University of Turku, Finland, has led the development of a new method to evaluate vaccine safety. The new method may significantly reduce the use of animal testing in the vaccine industry.

8 Dec 2020

Tension between awareness and fatigue can shift the shape of coronavirus pandemic

In the midst of the coronavirus pandemic, two human factors are battling it out: awareness of the virus's severe consequences and fatigue from nine months of pandemic precautions.

8 Dec 2020

G20 launches first report on digital health implementation approach to pandemic management

The first G20 report in area of digital health, Report on Digital Health Implementation Approach to Pandemic Management, was announced in advent of the G20 Summit.

8 Dec 2020

Reducing aerosol transmission could help tackle COVID-19 pandemic

Aerosols and their spread play an essential role in the transmission of COVID-19. However, the risk of transmission could be significantly reduced if more could be done to reduce indoor airborne viruses.

8 Dec 2020

Studies show IgA antibodies dominate early response to SARS-CoV-2 virus

A new study of more than 150 COVID-19 patients shows that IgA antibodies dominate the early response to the SARS-CoV-2 virus, coming on more quickly and strongly than IgG and IgM antibodies. This is a somewhat unexpected result, as IgM antibodies are usually the immune system's first responders.

7 Dec 2020

Vaccine News and Research

Latest Vaccine News and Research

Interim analysis of phase 3 study shows excellent efficacy of SARS-CoV-2 vaccine

Virginia Tech researchers awarded NIH grant to develop Zika virus vaccine

Different SARS-CoV-2 neutralization assays are reliable and concordant for antibody monitoring

Obesity increases the risk of severe COVID-19, study finds

UofL receives DoD funding to develop a nasal spray for preventing COVID-19

Considerable COVID-19 vaccination hesitancy in UK may affect herd immunity, study finds

It’s time to scare people about COVID

Interim results show Oxford COVID-19 vaccine protects against symptomatic disease

New report underscores the need to implement home care in all pandemic planning

Researchers assess the binding behavior of SARS-CoV-2 virus

UC Davis Health joins with Novavax to test a new experimental coronavirus vaccine

Researchers develop new method to evaluate vaccine safety

Tension between awareness and fatigue can shift the shape of coronavirus pandemic

G20 launches first report on digital health implementation approach to pandemic management

Reducing aerosol transmission could help tackle COVID-19 pandemic

Studies show IgA antibodies dominate early response to SARS-CoV-2 virus

Mount Sinai study shows strong immune response, durability of universal influenza virus vaccine

How effective is social distancing in preventing SARS-CoV-2 transmission? A New York case study

Xylitol and grapefruit seed extract shows promise in preventing SARS-CoV-2 infection, study finds

The intranasal route of immunization may offer effective protection against SARS-CoV-2

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Newsletters you may be interested in